These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15255089)
1. Health outcomes among patients receiving oseltamivir. Enger C; Nordstrom BL; Thakrar B; Sacks S; Rothman KJ Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):227-37. PubMed ID: 15255089 [TBL] [Abstract][Full Text] [Related]
2. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Smith JR; Sacks S Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705 [TBL] [Abstract][Full Text] [Related]
3. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Nordstrom BL; Oh K; Sacks ST; L'Italien GJ Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180 [TBL] [Abstract][Full Text] [Related]
4. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Blumentals WA; Schulman KL Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881 [TBL] [Abstract][Full Text] [Related]
5. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
6. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Orzeck EA; Shi N; Blumentals WA Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482 [TBL] [Abstract][Full Text] [Related]
7. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Casscells SW; Granger E; Kress AM; Linton A; Madjid M; Cottrell L Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):108-15. PubMed ID: 20031822 [TBL] [Abstract][Full Text] [Related]
8. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population]. Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558 [TBL] [Abstract][Full Text] [Related]
9. [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients]. Deng WW; Li QY; Zhong NS; Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2132-6. PubMed ID: 15730636 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232 [TBL] [Abstract][Full Text] [Related]
11. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681 [TBL] [Abstract][Full Text] [Related]
12. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. Ward P; Small I; Smith J; Suter P; Dutkowski R J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034 [TBL] [Abstract][Full Text] [Related]
14. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. Chang YM; Li WC; Huang CT; Huang CG; Tsao KC; Cheng YH; Chiang SL; Yang SY; Chen CH; Huang YC J Hosp Infect; 2008 Jan; 68(1):83-7. PubMed ID: 17945389 [TBL] [Abstract][Full Text] [Related]
15. Oseltamivir and delirious behavior in children with influenza. Okumura A; Kubota T; Kato T; Morishima T Pediatr Infect Dis J; 2006 Jun; 25(6):572. PubMed ID: 16732168 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic predictors of influenza virus positivity in children during the influenza season. Ohmit SE; Monto AS Clin Infect Dis; 2006 Sep; 43(5):564-8. PubMed ID: 16886147 [TBL] [Abstract][Full Text] [Related]
18. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Piedra PA; Schulman KL; Blumentals WA Pediatrics; 2009 Jul; 124(1):170-8. PubMed ID: 19564297 [TBL] [Abstract][Full Text] [Related]
19. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review. Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with early hospital discharge of adult influenza patients. Lee N; Chan PK; Choi KW; Lui G; Wong B; Cockram CS; Hui DS; Lai R; Tang JW; Sung JJ Antivir Ther; 2007; 12(4):501-8. PubMed ID: 17668558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]